The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Camlin Fine Sciences's current ratio for the quarter that ended in Mar. 2026 was 1.27.
Camlin Fine Sciences has a current ratio of 1.27. It generally indicates good short-term financial strength.
The historical rank and industry rank for Camlin Fine Sciences's Current Ratio or its related term are showing as below:
NSE:CAMLINFINE'
s Current Ratio Range Over the Past 10 Years
Min: 1.09 Med: 1.39 Max: 1.66
Current: 1.27
During the past 13 years, Camlin Fine Sciences's highest Current Ratio was 1.66. The lowest was 1.09. And the median was 1.39.
NSE:CAMLINFINE's Current Ratio is ranked worse than 73.99% of 1615
companies
in the Chemicals industry
Industry Median: 1.89
vs NSE:CAMLINFINE: 1.27
Camlin Fine Sciences (NSE:CAMLINFINE) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Camlin Fine Sciences Current Ratio Related Terms
Camlin Fine Sciences Current Ratio Historical Data
* Premium members only.
The historical data trend for Camlin Fine Sciences's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CAMLINFINE vs LIN, SHW, ECL: Current Ratio Comparison
For the Specialty Chemicals subindustry, Camlin Fine Sciences's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Camlin Fine Sciences Current Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's Current Ratio distribution charts can be found below:
* The bar in red indicates where Camlin Fine Sciences's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camlin Fine Sciences (NSE:CAMLINFINE) has a Current Ratio of 1.27 as of Mar. 2026. This is near median its historical median of 1.39. Over the past decade, Camlin Fine Sciences' Current Ratio has ranged from 1.09 to 1.66. According to the industry distribution chart, Camlin Fine Sciences ranks #1195 out of 1615 companies in the Chemicals industry, placing it in the top 74%.
Is Camlin Fine Sciences' Current Ratio too high?
Camlin Fine Sciences' current Current Ratio of 1.27 is near median its 10-year median of 1.39. Over the past 10 years, this metric has ranged from a low of 1.09 to a high of 1.66. The Chemicals industry median Current Ratio is 1.89. Camlin Fine Sciences' value of 1.27 is 32.8% below this industry median. Based on the distribution chart, Camlin Fine Sciences ranks #1195 out of 1615 companies in the Chemicals industry, which is below the industry midpoint. Overall, Camlin Fine Sciences has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Camlin Fine Sciences' Current Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Camlin Fine Sciences ranks #1195 out of 1615 companies for Current Ratio. This places Camlin Fine Sciences in the lower half of its industry. The industry median Current Ratio is 1.89. Camlin Fine Sciences' value of 1.27 is 32.8% below this benchmark. Historically, Camlin Fine Sciences' own Current Ratio has ranged from 1.09 to 1.66 over the past decade. While the company's 10-year median is 1.39 vs. the industry median of 1.89, Camlin Fine Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Chemicals company?
The median Current Ratio among Chemicals companies is 1.89, based on 1,615 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Camlin Fine Sciences's current Current Ratio of 1.27 is 32.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Current Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camlin Fine Sciences's current Current Ratio is 1.27, which is near median its own 10-year median of 1.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camlin Fine Sciences stock overvalued right now?
Based on GuruFocus' analysis, Camlin Fine Sciences (NSE:CAMLINFINE) is currently considered Fairly Valued. The stock's GF Value™ is ₹142.27, compared to a current price of ₹136.37 — trading 4.1% below its estimated fair value. The current Current Ratio is 1.27, which is near median its 10-year median of 1.39 and 32.8% below the Chemicals industry median of 1.89. Camlin Fine Sciences' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Camlin Fine Sciences (NSE:CAMLINFINE), the current Current Ratio is 1.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?
Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued.
The current stock price of ₹136.37 is trading 4.1% below its estimated GF Value™ of ₹142.27.
GuruFocus considers Camlin Fine Sciences to be Fairly Valued.
Key valuation signals for NSE:CAMLINFINE:
Current Ratio: 1.27 (near median its 10-year median of 1.39)
GF Value™: ₹142.27 vs. price of ₹136.37 (4.1% below fair value)
Industry Position: 32.8% below the Chemicals median (#1195 of 1615)
No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
58GF Score
Get the complete analysis for NSE:CAMLINFINE
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CAMLINFINE has been successfully added to your 
